Trademarkia Logo

Australia

AU$
LYVFIRLA
Registered: Registered/protected

Last updated on 11 Jan 2021

Owner Info

Intercept Pharmaceuticals, Inc. a Delaware corporation

10 Hudson Yards, 37th Floor

New York, New York, 10001 UNITED STATES OF AMERICA,

Serial Number

2126259 filed on 7 Oct 2020

Correspondent

Allens Patent & Trade Mark Attorneys

101 Collins St,

MELBOURNE, VIC, 3001 AUSTRALIA,

LYVFIRLA

Classification Information


Class [005]
Pharmaceutical preparations; pharmaceutical preparations for the treatment of liver diseases, disorders and conditions; pharmaceuticals for treating n Read More

Mark Details


Serial Number

2126259

Registered On

7 Oct 2020

Renewal On

7 Oct 2030

Mark Type

WORD

Priority Claim (Convention Details)


Date

20 Apr 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
11th Jan 2021IP Right Registered correspondence sent
11th Jan 2021IP Right Registration Published
11th Jan 2021Status change to Registered/Protected
5th Nov 2020Application Accepted correspondence sent
4th Nov 2020IP Right has been Examined
4th Nov 2020IP Right Acceptance Published
4th Nov 2020Status change to Accepted
13th Oct 2020Awaiting examination
13th Oct 2020Examination expedited
8th Oct 2020IP Right Filed correspondence sent